Skip to main content
BROOKS LABORATORIES LIMITED logo

BROOKS LABORATORIES LIMITED — Investor Relations & Filings

Ticker · BROOKS ISIN · INE650L01011 LEI · 984500FY0879C7971B73 BSE.NS Manufacturing
Filings indexed 498 across all filing types
Latest filing 2022-08-21 Regulatory Filings
Country IN India
Listing BSE.NS BROOKS

About BROOKS LABORATORIES LIMITED

https://www.brookslabs.net/

Brooks Laboratories Limited is a pharmaceutical manufacturing enterprise specializing in Contract Research and Manufacturing Services (CRAMS). The company focuses on the production of a diverse range of pharmaceutical formulations, including beta-lactam and non-beta-lactam products. Its portfolio encompasses various dosage forms such as dry powder injections, liquid injections, tablets, and capsules. Key therapeutic segments served include antibiotics, cardiovascular, gastrointestinal, and pain management. The company operates advanced manufacturing facilities designed to meet international quality standards, providing integrated solutions from formulation development to commercial-scale production. Brooks Laboratories emphasizes quality control and regulatory compliance to support its domestic and international client base.

Recent filings

Filing Released Lang Actions
General updates
Regulatory Filings
2022-08-21 English
Newspaper Advertisements
Regulatory Filings
2022-08-12 English
Disclosure of other UPSI/material event
Regulatory Filings
2022-08-10 English
Outcome of Board Meeting
Regulatory Filings
2022-08-10 English
Board Meeting — Financial results
Regulatory Filings Classification · 100% confidence The document text is extremely short (79 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document does not fit any specific category and defaults to the fallback category for miscellaneous filings.
2022-08-03 English
Closure of trading window
Regulatory Filings Classification · 100% confidence The document text is essentially empty, containing only placeholders and an omitted picture reference, with a very short length of 95 characters. There is no substantive content, no financial data, no announcements, no regulatory references, or any report details. Given the extreme brevity and lack of content, this cannot be classified as any substantive report or announcement. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2022-06-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.